Literature DB >> 23266571

Understanding genomic alterations in cancer genomes using an integrative network approach.

Edwin Wang1.   

Abstract

In recent years, cancer genome sequencing and other high-throughput studies of cancer genomes have generated many notable discoveries. In this review, novel genomic alteration mechanisms, such as chromothripsis (chromosomal crisis) and kataegis (mutation storms), and their implications for cancer are discussed. Genomic alterations spur cancer genome evolution. Thus, the relationship between cancer clonal evolution and cancer stems cells is commented. The key question in cancer biology concerns how these genomic alterations support cancer development and metastasis in the context of biological functioning. Thus far, efforts such as pathway analysis have improved the understanding of the functional contributions of genetic mutations and DNA copy number variations to cancer development, progression and metastasis. However, the known pathways correspond to a small fraction, plausibly 5-10%, of somatic mutations and genes with an altered copy number. To develop a comprehensive understanding of the function of these genomic alterations in cancer, an integrative network framework is proposed and discussed. Finally, the challenges and the directions of studying cancer omic data using an integrative network approach are commented. Crown
Copyright © 2012. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cancer genome evolution; Cancer genome sequencing; Chromothripsis; Kataegis; Network; Systems biology

Mesh:

Substances:

Year:  2012        PMID: 23266571     DOI: 10.1016/j.canlet.2012.11.050

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  38 in total

1.  Differential Neuroproteomic and Systems Biology Analysis of Spinal Cord Injury.

Authors:  Ahmed Moghieb; Helen M Bramlett; Jyotirmoy H Das; Zhihui Yang; Tyler Selig; Richard A Yost; Michael S Wang; W Dalton Dietrich; Kevin K W Wang
Journal:  Mol Cell Proteomics       Date:  2016-05-05       Impact factor: 5.911

Review 2.  Prostate zones and cancer: lost in transition?

Authors:  Amin Ali; Alexander Du Feu; Pedro Oliveira; Ananya Choudhury; Robert G Bristow; Esther Baena
Journal:  Nat Rev Urol       Date:  2021-10-19       Impact factor: 14.432

3.  An M0 macrophage-related prognostic model for hepatocellular carcinoma.

Authors:  Yiya Zhang; Ju Zou; Ruochan Chen
Journal:  BMC Cancer       Date:  2022-07-19       Impact factor: 4.638

4.  Treatment scheduling effects on the evolution of drug resistance in heterogeneous cancer cell populations.

Authors:  Gauri A Patwardhan; Michal Marczyk; Vikram B Wali; David F Stern; Lajos Pusztai; Christos Hatzis
Journal:  NPJ Breast Cancer       Date:  2021-05-26

5.  Predicting lncRNA-disease associations and constructing lncRNA functional similarity network based on the information of miRNA.

Authors:  Xing Chen
Journal:  Sci Rep       Date:  2015-08-17       Impact factor: 4.379

6.  Prediction of oncogenic interactions and cancer-related signaling networks based on network topology.

Authors:  Marcio Luis Acencio; Luiz Augusto Bovolenta; Esther Camilo; Ney Lemke
Journal:  PLoS One       Date:  2013-10-25       Impact factor: 3.240

7.  Molecular correlates of immune cytolytic subgroups in colorectal cancer by integrated genomics analysis.

Authors:  Constantinos Roufas; Ilias Georgakopoulos-Soares; Apostolos Zaravinos
Journal:  NAR Cancer       Date:  2021-03-02

8.  Identifying potential cancer driver genes by genomic data integration.

Authors:  Yong Chen; Jingjing Hao; Wei Jiang; Tong He; Xuegong Zhang; Tao Jiang; Rui Jiang
Journal:  Sci Rep       Date:  2013-12-18       Impact factor: 4.379

Review 9.  Fractal dimension of chromatin: potential molecular diagnostic applications for cancer prognosis.

Authors:  Konradin Metze
Journal:  Expert Rev Mol Diagn       Date:  2013-09       Impact factor: 5.225

10.  The pathway ontology - updates and applications.

Authors:  Victoria Petri; Pushkala Jayaraman; Marek Tutaj; G Thomas Hayman; Jennifer R Smith; Jeff De Pons; Stanley Jf Laulederkind; Timothy F Lowry; Rajni Nigam; Shur-Jen Wang; Mary Shimoyama; Melinda R Dwinell; Diane H Munzenmaier; Elizabeth A Worthey; Howard J Jacob
Journal:  J Biomed Semantics       Date:  2014-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.